Arvinas, Inc. (ARVN)
7.30
-0.42
(-5.44%)
USD |
NASDAQ |
Oct 23, 16:00
7.28
-0.02
(-0.27%)
Pre-Market: 09:13
Arvinas Price : 7.30 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 7.70 | 7.70 | 7.20 | 7.30 | 651573.0 |
| Oct 22, 2026 | 7.53 | 7.74 | 7.40 | 7.72 | 620197.0 |
| Oct 21, 2026 | 7.62 | 7.79 | 7.54 | 7.555 | 653596.0 |
| Oct 20, 2026 | 7.28 | 7.74 | 7.28 | 7.66 | 540851.0 |
| Oct 19, 2026 | 7.06 | 7.29 | 6.95 | 7.26 | 795637.0 |
| Oct 16, 2026 | 7.16 | 7.30 | 6.925 | 6.97 | 761289.0 |
| Oct 15, 2026 | 6.88 | 7.18 | 6.83 | 7.16 | 606046.0 |
| Oct 14, 2026 | 6.77 | 6.96 | 6.74 | 6.82 | 856960.0 |
| Oct 13, 2026 | 7.54 | 7.54 | 6.80 | 6.84 | 852894.0 |
| Oct 12, 2026 | 7.73 | 7.73 | 7.44 | 7.45 | 502649.0 |
| Oct 09, 2026 | 7.46 | 7.74 | 7.46 | 7.64 | 560049.0 |
| Oct 08, 2026 | 7.365 | 7.55 | 7.245 | 7.51 | 1.017M |
| Oct 07, 2026 | 7.25 | 7.46 | 7.22 | 7.45 | 601836.0 |
| Oct 06, 2026 | 7.49 | 7.49 | 7.275 | 7.31 | 585799.0 |
| Oct 05, 2026 | 7.46 | 7.505 | 7.22 | 7.46 | 628531.0 |
| Oct 02, 2026 | 7.51 | 7.52 | 7.30 | 7.41 | 585123.0 |
| Oct 01, 2026 | 7.74 | 7.82 | 7.43 | 7.43 | 807322.0 |
| Sep 30, 2026 | 7.55 | 8.04 | 7.442 | 7.735 | 1.061M |
| Sep 29, 2026 | 7.49 | 7.52 | 7.36 | 7.50 | 496059.0 |
| Sep 28, 2026 | 7.54 | 7.565 | 7.38 | 7.51 | 512105.0 |
| Sep 25, 2026 | 7.78 | 7.81 | 7.535 | 7.59 | 713363.0 |
| Sep 24, 2026 | 7.81 | 7.819 | 7.39 | 7.79 | 1.218M |
| Sep 23, 2026 | 8.60 | 8.64 | 7.815 | 7.83 | 761366.0 |
| Sep 22, 2026 | 8.37 | 8.57 | 8.30 | 8.51 | 685448.0 |
| Sep 21, 2026 | 8.37 | 8.44 | 8.21 | 8.30 | 639844.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 0.95 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Fulcrum Therapeutics, Inc. | 3.68 |
| Definium Therapeutics, Inc. | 35.67 |
| LeonaBio, Inc. | 4.84 |
Price Related Metrics
| PE Ratio | 45.51 |
| PS Ratio | 1.543 |
| Price to Book Value | 0.8479 |
| Earnings Yield | 2.20% |
| Market Cap | 476.69M |
| Normalized PE Ratio | 33.36 |